KR100389292B1 - 신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 - Google Patents
신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 Download PDFInfo
- Publication number
- KR100389292B1 KR100389292B1 KR10-2001-0003503A KR20010003503A KR100389292B1 KR 100389292 B1 KR100389292 B1 KR 100389292B1 KR 20010003503 A KR20010003503 A KR 20010003503A KR 100389292 B1 KR100389292 B1 KR 100389292B1
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- positively charged
- iii
- carbamate
- liposomes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (5)
- (ⅰ) 아미노 작용기가 보호된 아스파르트산염(Ⅱ)을 수화 톨루엔술폰산 또는 무수 톨루엔인 산촉매하에서 알코올(Ⅲ)과 에스테르화 반응 또는 짝지움 반응에 의하여 화합물(Ⅳ)을 수득하는 공정;(ⅱ) 전기 수득된 화합물(Ⅳ)의 보호기를 무수 테트라하이드로퓨란(THF) 용매내에서 5 내지 20%(w/w)의 Pd/C 또는 수소의 존재하에 제거하여 화합물(Ⅴ)를 수득하는 공정;(ⅲ) 전기 수득된 화합물(Ⅴ)를 화합물(Ⅵ)과 짝지움 반응을 시킴으로써 화합물(Ⅶ)를 수득하는 공정;(ⅳ) 전기 수득된 화합물(Ⅶ)를 Cl-디옥산 용액, 무수 디옥산 또는 이들의 혼합물과 0 내지 10℃에서 1 내지 6시간 동안 반응시켜서, R3를 제거하여 화합물(Ⅷ)을 수득하는 공정; 및,(ⅴ) 전기 수득된 화합물(Ⅷ)에 염을 형성시킴으로써 하기 일반식(Ⅰ)의 양전하 지질을 수득하는 공정을 포함하는 양전하 지질의 제조방법:상기 식에서,R은 수소, C10-C18의 알킬기 또는 C10-C18의 알켄기이고;R1및 R3는 벤질 카르바메이트(benzyl carbamate, Cbz), p-메톡시벤질카르바메이트(p-methoxybenzyl carbamate, Moz), p-브로모벤질카르바메이트(p-bromobenzyl carbamate), 9-플루오로메틸 카르바메이트(9-fluoromethyl carbamate, FMOC), t-부틸 카르바메이트(t-butyl carbamate, t-Boc) 또는 1-아다만틸카르바메이트(1-adamantyl carbamate, Adoc)이며; 및,X는 F, Cl, Br, I, CF3CO2, HSO4또는 NH3이다.
- 제 1항에 있어서,디사이클로헥실카르보디이미드(dicyclohexylcarbodiimide, DCC)또는 디이소프로필디이미드(diisopropyldiimide, DIC)를 사용하여(ⅰ) 공정의 짝지움 반응을 수행하는 것을 특징으로 하는양전하 지질의 제조방법.
- 제 1항에 있어서,디터셔리 부틸 디카르보네이트(di-tert-butyl dicarbonate), NaOH,THF 및 물의 존재하에 (ⅲ) 공정의 짝지움 반응을 수행하는 것을특징으로 하는양전하 지질의 제조방법.
- 다음의 일반식(Ⅰ)으로 나타내어지는 양전하 지질:상기 식에서,R은 수소, C10-C18의 알킬기 또는 C10-C18의 알켄기이고; 및,X는 F, Cl, Br, I, CF3CO2, HSO4또는 NH3이다.
- 제 4항의 양전하 지질과, 콜레스테롤 또는 디올레일포스파티딜에타놀아민을 1:1의 몰랄농도로 혼합하여 유기용매에 용해시킨 후, 유기용매를 제거하고 수화시켜 1 내지 70℃에서 혼합함으로써 제조되는 양전하지질을 함유하는 리포솜.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0003503A KR100389292B1 (ko) | 2001-01-22 | 2001-01-22 | 신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0003503A KR100389292B1 (ko) | 2001-01-22 | 2001-01-22 | 신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020062479A KR20020062479A (ko) | 2002-07-26 |
KR100389292B1 true KR100389292B1 (ko) | 2003-06-27 |
Family
ID=27692392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0003503A KR100389292B1 (ko) | 2001-01-22 | 2001-01-22 | 신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100389292B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100464787B1 (ko) * | 2002-03-20 | 2005-01-06 | 박용석 | 글루탐산염을 이용한 양전하 지질의 제조방법 |
KR101242113B1 (ko) * | 2010-10-22 | 2013-03-19 | 고마바이오텍(주) | 유전자 전달용 양이온성 센다이 f/hn 바이로좀 복합체 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4026915A (en) * | 1975-08-27 | 1977-05-31 | S. C. Johnson & Son, Inc. | Di-mixed alky aspartate salts |
US4399163A (en) * | 1980-11-05 | 1983-08-16 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
JPH03148247A (ja) * | 1989-08-31 | 1991-06-25 | Warner Lambert Co | Acat阻害剤 |
JPH03261750A (ja) * | 1990-03-09 | 1991-11-21 | Res Dev Corp Of Japan | ポリフルオロアルキル化合物及び化合物薄膜の製造方法 |
JPH04330046A (ja) * | 1991-03-28 | 1992-11-18 | Res Dev Corp Of Japan | ポリフルオロアルキル化合物の製造方法 |
JPH10101633A (ja) * | 1996-09-27 | 1998-04-21 | Tosoh Corp | 高光学純度光学活性アミノ酸エステルの製造法 |
JPH10237032A (ja) * | 1996-12-27 | 1998-09-08 | Fuji Photo Film Co Ltd | アミノポリカルボン酸系キレート剤、その重金属化合物、写真用添加物、および処理方法 |
-
2001
- 2001-01-22 KR KR10-2001-0003503A patent/KR100389292B1/ko active IP Right Grant
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4026915A (en) * | 1975-08-27 | 1977-05-31 | S. C. Johnson & Son, Inc. | Di-mixed alky aspartate salts |
US4399163A (en) * | 1980-11-05 | 1983-08-16 | Pfizer Inc. | Branched amides of L-aspartyl-D-amino acid dipeptides |
JPH03148247A (ja) * | 1989-08-31 | 1991-06-25 | Warner Lambert Co | Acat阻害剤 |
JPH03261750A (ja) * | 1990-03-09 | 1991-11-21 | Res Dev Corp Of Japan | ポリフルオロアルキル化合物及び化合物薄膜の製造方法 |
JPH04330046A (ja) * | 1991-03-28 | 1992-11-18 | Res Dev Corp Of Japan | ポリフルオロアルキル化合物の製造方法 |
JPH10101633A (ja) * | 1996-09-27 | 1998-04-21 | Tosoh Corp | 高光学純度光学活性アミノ酸エステルの製造法 |
JPH10237032A (ja) * | 1996-12-27 | 1998-09-08 | Fuji Photo Film Co Ltd | アミノポリカルボン酸系キレート剤、その重金属化合物、写真用添加物、および処理方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100464787B1 (ko) * | 2002-03-20 | 2005-01-06 | 박용석 | 글루탐산염을 이용한 양전하 지질의 제조방법 |
KR101242113B1 (ko) * | 2010-10-22 | 2013-03-19 | 고마바이오텍(주) | 유전자 전달용 양이온성 센다이 f/hn 바이로좀 복합체 |
Also Published As
Publication number | Publication date |
---|---|
KR20020062479A (ko) | 2002-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10233148B2 (en) | Aromatic ionizable cationic lipid | |
US6020526A (en) | Amide-based cationic lipids | |
EP0968227B1 (en) | Dimeric cationic lipids on dicystine basis | |
US8580297B2 (en) | Components for producing amphoteric liposomes | |
US5877220A (en) | Amide-based oligomeric cationic lipids | |
WO1997003939A9 (en) | Novel amide-based cationic lipids | |
CA2413629A1 (en) | Solid method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same | |
US6339173B1 (en) | Amide-based cationic lipids | |
CA2223088A1 (en) | Novel carbamate-based cationic lipids | |
WO1996040726A9 (en) | Novel carbamate-based cationic lipids | |
WO1998039358A9 (en) | Oligomeric cationic lipids | |
FR2759382A1 (fr) | Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique | |
CN117440943A (zh) | 含氮的阳离子脂质及其应用 | |
KR100389292B1 (ko) | 신규한 양전하 지질 및 전기 양전하 지질을 함유하는 리포솜 | |
US20080167491A1 (en) | T-butoxycarbonylaminoethylamine for the Synthesis of PNA Monomer Units, Amino Acid Derivatives, Intermediates Thereof, and Processes for Productions of Them | |
EP1133465B1 (en) | Amphiphilic polyamine compounds | |
KR100464787B1 (ko) | 글루탐산염을 이용한 양전하 지질의 제조방법 | |
US5506267A (en) | Thioglycerol derivatives | |
Gorohovsky et al. | Novel N-quinonyl amino acids and their transformation to 3-substituted p-isoxazinones | |
CA2260450A1 (en) | Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril | |
WO2023086514A1 (en) | Ionizable cationic lipids for rna delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130605 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140603 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150601 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20160602 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170608 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190610 Year of fee payment: 17 |